About us

With ten years in business Coriolis has become a globally leading service provider in the field of BIOPHARMACEUTICAL DRUG DEVELOPMENT.

Our service portfolio includes FORMULATION DEVELOPMENT (liquid and lyophilized) for biopharmaceuticals including high concentrated and S1 / S2 classified material, LYOPHILIZATION CYCLE DEVELOPMENT, FORCED DEGRADATION STUDIES and STABILITY TESTING, COMPARABILITY STUDIES, and CONTRACT ANALYTICAL SERVICES for biopharmaceuticals (R&D and GMP compliant) and ANALYSIS of aggregates and subvisible particles.

Coriolis offers a unique analytical service portfolio for subvisible particle analysis, troubleshooting or regulatory support. Methods include MFI, LO, RMM, AUC (including OptimaAUC) and FIELD FLOW FRACTIONATION.

For gene therapy and viral based vaccine products Coriolis is equipped to support particle morphology, aggregation, size distribution, and purity analysis using e.g. AUC, TEM, NTA, and DLS.

Products and services

Coriolis is specialised in the provision of:

· Formulation development services for liquid and lyophilised products

                · Pre-formulation and candidate selection

                · Early stage formulation development

                · Late phase formulation development

                · Lyophilisation cycle optimisation

                · Scale-up and transfer studies

· Support in container closure system selection

· In-use stability studies

· Stability testing including forced degradation studies

· R&D and GMP-compliant contract analytical services

· Orthogonal analysis of subvisible aggregates and particles

· Testing of S1 and S2 GMO material

· Polysorbate analytics

· Outstanding scientific expertise

Address
Coriolis Pharma Research GmbH
Fraunhoferstr. 18 b
82152 Martinsried
Germany

Phone: +49 89 4177600
Fax: +49 89 417760222
Internet: www.coriolis-pharma.com
E-mail: Send message

Contact person

Joerg Mueller
Business Development Manager
Phone: +49 89 417760111
E-mail: Send message

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We use cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection